Investigation of anticancer mechanism of thiadiazole-based compound in human non-small cell lung cancer A549 cells

Jui Yi Chou, Shin Yu Lai, Shiow Lin Pan, Guey Mei Jow, Ji Wang Chern, Jih Hwa Guh

Research output: Contribution to journalArticle

123 Citations (Scopus)

Abstract

In this study, we have synthesized several compounds and examined their cytotoxic effects on human non-small cell lung cancer A549 cells. We found that GO-13 ((E,E)-2,5-bis[4-(3-dimethyl-aminopropoxy)styryl]-1,3,4-thiadiazole) is the most effective one by the MTT assay. Furthermore, the GO-13-induced apoptotic reaction was identified based on several criteria, such as negative release reaction of lactate dehydrogenase and positive labeling of annexin V and terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) techniques. GO-13 induced the apoptosis in A549 cells in a concentration- and time-dependent manner. The data demonstrate that the regulations of p38 mitogen-activated protein kinase and protein kinase C was not involved in the GO-13-mediated mechanism. However, GO-13 significantly induced a down-regulation of Bcl-XL expression in a short-term treatment (less than 3hr), whereas stimulated up-regulation of Bax expression in a long-term treatment (24hr) indicating their involvement in GO-13 action. GO-13-mediated apoptosis is also positively correlated with the increase in caspase-3 activity. Worth noting is the fact that GO-13 did not modify the phosphorylation level of Akt/protein kinase B (PKB) until a 24-hr exposure was carried out indicating that the inhibition of Akt/PKB activation was involved in the late-phase apoptosis. Besides the anticancer activity, GO-13 also showed equivalent anti-angiogenic activity in the nude mice angiogenesis model. In summary, we conclude that GO-13 is the most effective anticancer compound in our screening tests. It induced the early-phase apoptosis in A549 cells via the Bcl-XL down-regulation, and that of the late-phase through up-regulation of Bax expression as well as inhibition of Akt/PKB activation.

Original languageEnglish
Pages (from-to)115-124
Number of pages10
JournalBiochemical Pharmacology
Volume66
Issue number1
DOIs
Publication statusPublished - Jul 1 2003
Externally publishedYes

Fingerprint

Thiadiazoles
Non-Small Cell Lung Carcinoma
Proto-Oncogene Proteins c-akt
Cells
Apoptosis
p38 Mitogen-Activated Protein Kinases
Labeling
Up-Regulation
Down-Regulation
Chemical activation
Phosphorylation
DNA Nucleotidylexotransferase
Annexin A5
Mitogen-Activated Protein Kinase Kinases
L-Lactate Dehydrogenase
Nude Mice
Caspase 3
Protein Kinase C
Assays
Screening

Keywords

  • Apoptosis
  • Bax
  • Bcl-X
  • Phosphoinositide 3-kinase
  • Thiadiazole

ASJC Scopus subject areas

  • Pharmacology

Cite this

Investigation of anticancer mechanism of thiadiazole-based compound in human non-small cell lung cancer A549 cells. / Chou, Jui Yi; Lai, Shin Yu; Pan, Shiow Lin; Jow, Guey Mei; Chern, Ji Wang; Guh, Jih Hwa.

In: Biochemical Pharmacology, Vol. 66, No. 1, 01.07.2003, p. 115-124.

Research output: Contribution to journalArticle

Chou, Jui Yi ; Lai, Shin Yu ; Pan, Shiow Lin ; Jow, Guey Mei ; Chern, Ji Wang ; Guh, Jih Hwa. / Investigation of anticancer mechanism of thiadiazole-based compound in human non-small cell lung cancer A549 cells. In: Biochemical Pharmacology. 2003 ; Vol. 66, No. 1. pp. 115-124.
@article{7d393148f22547ba96b59f00c93f8e1c,
title = "Investigation of anticancer mechanism of thiadiazole-based compound in human non-small cell lung cancer A549 cells",
abstract = "In this study, we have synthesized several compounds and examined their cytotoxic effects on human non-small cell lung cancer A549 cells. We found that GO-13 ((E,E)-2,5-bis[4-(3-dimethyl-aminopropoxy)styryl]-1,3,4-thiadiazole) is the most effective one by the MTT assay. Furthermore, the GO-13-induced apoptotic reaction was identified based on several criteria, such as negative release reaction of lactate dehydrogenase and positive labeling of annexin V and terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) techniques. GO-13 induced the apoptosis in A549 cells in a concentration- and time-dependent manner. The data demonstrate that the regulations of p38 mitogen-activated protein kinase and protein kinase C was not involved in the GO-13-mediated mechanism. However, GO-13 significantly induced a down-regulation of Bcl-XL expression in a short-term treatment (less than 3hr), whereas stimulated up-regulation of Bax expression in a long-term treatment (24hr) indicating their involvement in GO-13 action. GO-13-mediated apoptosis is also positively correlated with the increase in caspase-3 activity. Worth noting is the fact that GO-13 did not modify the phosphorylation level of Akt/protein kinase B (PKB) until a 24-hr exposure was carried out indicating that the inhibition of Akt/PKB activation was involved in the late-phase apoptosis. Besides the anticancer activity, GO-13 also showed equivalent anti-angiogenic activity in the nude mice angiogenesis model. In summary, we conclude that GO-13 is the most effective anticancer compound in our screening tests. It induced the early-phase apoptosis in A549 cells via the Bcl-XL down-regulation, and that of the late-phase through up-regulation of Bax expression as well as inhibition of Akt/PKB activation.",
keywords = "Apoptosis, Bax, Bcl-X, Phosphoinositide 3-kinase, Thiadiazole",
author = "Chou, {Jui Yi} and Lai, {Shin Yu} and Pan, {Shiow Lin} and Jow, {Guey Mei} and Chern, {Ji Wang} and Guh, {Jih Hwa}",
year = "2003",
month = "7",
day = "1",
doi = "10.1016/S0006-2952(03)00254-5",
language = "English",
volume = "66",
pages = "115--124",
journal = "Biochemical Pharmacology",
issn = "0006-2952",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Investigation of anticancer mechanism of thiadiazole-based compound in human non-small cell lung cancer A549 cells

AU - Chou, Jui Yi

AU - Lai, Shin Yu

AU - Pan, Shiow Lin

AU - Jow, Guey Mei

AU - Chern, Ji Wang

AU - Guh, Jih Hwa

PY - 2003/7/1

Y1 - 2003/7/1

N2 - In this study, we have synthesized several compounds and examined their cytotoxic effects on human non-small cell lung cancer A549 cells. We found that GO-13 ((E,E)-2,5-bis[4-(3-dimethyl-aminopropoxy)styryl]-1,3,4-thiadiazole) is the most effective one by the MTT assay. Furthermore, the GO-13-induced apoptotic reaction was identified based on several criteria, such as negative release reaction of lactate dehydrogenase and positive labeling of annexin V and terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) techniques. GO-13 induced the apoptosis in A549 cells in a concentration- and time-dependent manner. The data demonstrate that the regulations of p38 mitogen-activated protein kinase and protein kinase C was not involved in the GO-13-mediated mechanism. However, GO-13 significantly induced a down-regulation of Bcl-XL expression in a short-term treatment (less than 3hr), whereas stimulated up-regulation of Bax expression in a long-term treatment (24hr) indicating their involvement in GO-13 action. GO-13-mediated apoptosis is also positively correlated with the increase in caspase-3 activity. Worth noting is the fact that GO-13 did not modify the phosphorylation level of Akt/protein kinase B (PKB) until a 24-hr exposure was carried out indicating that the inhibition of Akt/PKB activation was involved in the late-phase apoptosis. Besides the anticancer activity, GO-13 also showed equivalent anti-angiogenic activity in the nude mice angiogenesis model. In summary, we conclude that GO-13 is the most effective anticancer compound in our screening tests. It induced the early-phase apoptosis in A549 cells via the Bcl-XL down-regulation, and that of the late-phase through up-regulation of Bax expression as well as inhibition of Akt/PKB activation.

AB - In this study, we have synthesized several compounds and examined their cytotoxic effects on human non-small cell lung cancer A549 cells. We found that GO-13 ((E,E)-2,5-bis[4-(3-dimethyl-aminopropoxy)styryl]-1,3,4-thiadiazole) is the most effective one by the MTT assay. Furthermore, the GO-13-induced apoptotic reaction was identified based on several criteria, such as negative release reaction of lactate dehydrogenase and positive labeling of annexin V and terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) techniques. GO-13 induced the apoptosis in A549 cells in a concentration- and time-dependent manner. The data demonstrate that the regulations of p38 mitogen-activated protein kinase and protein kinase C was not involved in the GO-13-mediated mechanism. However, GO-13 significantly induced a down-regulation of Bcl-XL expression in a short-term treatment (less than 3hr), whereas stimulated up-regulation of Bax expression in a long-term treatment (24hr) indicating their involvement in GO-13 action. GO-13-mediated apoptosis is also positively correlated with the increase in caspase-3 activity. Worth noting is the fact that GO-13 did not modify the phosphorylation level of Akt/protein kinase B (PKB) until a 24-hr exposure was carried out indicating that the inhibition of Akt/PKB activation was involved in the late-phase apoptosis. Besides the anticancer activity, GO-13 also showed equivalent anti-angiogenic activity in the nude mice angiogenesis model. In summary, we conclude that GO-13 is the most effective anticancer compound in our screening tests. It induced the early-phase apoptosis in A549 cells via the Bcl-XL down-regulation, and that of the late-phase through up-regulation of Bax expression as well as inhibition of Akt/PKB activation.

KW - Apoptosis

KW - Bax

KW - Bcl-X

KW - Phosphoinositide 3-kinase

KW - Thiadiazole

UR - http://www.scopus.com/inward/record.url?scp=0038005576&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038005576&partnerID=8YFLogxK

U2 - 10.1016/S0006-2952(03)00254-5

DO - 10.1016/S0006-2952(03)00254-5

M3 - Article

VL - 66

SP - 115

EP - 124

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

SN - 0006-2952

IS - 1

ER -